Testing effectiveness (Phase 2)UnknownNCT03990103
What this trial is testing
S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites
Who this might be right for
Metastatic Gastric Adenocarcinoma
China Medical University, China 66